Ackrell Capital report shows modest capital raised by U.S. publicly traded cannabis companies in 2017Ackrell Capital Cannabis OTC Market Valuation Table (2017)
Case Filekaggle-ho-024760House OversightCannabis Investment Report – December 2017 Financial Metrics
Unknown1p1 persons
Case File
kaggle-ho-024760House OversightCannabis Investment Report – December 2017 Financial Metrics
Cannabis Investment Report – December 2017 Financial Metrics The document is a financial summary of cannabis‑related public companies with valuation multiples and revenue figures. It contains no references to political figures, government agencies, foreign leaders, or alleged misconduct, offering no investigative leads of interest. Key insights: Provides LTM and forward revenue, EBITDA, and enterprise value for several cannabis firms.; Lists stock tickers and market percentages for each company.; Notes methodology for handling negative or extreme multiples.
Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024760
Pages
1
Persons
1
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
Advertisement
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.